The company expects full year 2023 revenue to be in a range from $18.0-$21.0M.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on AFIB:
- Acutus Medical Reports Fourth Quarter and Full Year 2022 Financial Results
- Acutus Medical management to meet virtually with BTIG
- Acutus Medical to Announce Fourth Quarter and Full Year 2022 Financial Results
- Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Late-Breaking ACQFORCE FLUTTER Trial Meets Primary Endpoint for Safety and Efficacy with the First Gold-Tipped Contact Force Sensing Ablation Catheter